Clinical Efficiency Analysis of Share Decision Making in the Atrial Fibrillation Patients

Cheng, Hao‐Min; Chang, Hong Di; Huang, Hsin-Chan; Hsu, Hsiao-Fen; Lee, Chih-Yi; Sheu, Mei-Jyh; Chiu, Hsiao-Hui

doi:10.20849/ijsn.v5i3.765

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cheng et al found that anxiety decreased from 3.5 points to 2.1 points (p < 0.05) in patients with AF using SDM [15], which is consistent with the present study showing that SDM can reduce patients' anxiety. Our study showed that the willingness to use medication increased from 76.9% to 88.5% in AF patients with SDM.…”

Section: Influence Of Sdm On Patients' Decision Makingsupporting

confidence: 92%

Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation

Chiu,

Chang,

Cheng

et al. 2023

BMC Med Inform Decis Mak

Self Cite

View full text Add to dashboard Cite

Background Treatment with oral anticoagulants (OACs) could prevent stroke in atrial fibrillation (AF), but side effects developed due to OACs may cause patients anxiety during decision making. This study aimed to investigate whether shared decision making (SDM) reduces anxiety and improves adherence to stroke prevention measures in patients with AF. Methods A one-group pretest–posttest design using a questionnaire survey was applied at the outpatient cardiology clinic between July 2019 until September 2020. A Patient Decision Aid (PDA) tool was used for the completion of the questionnaire survey after health education and counseling. Ten questions were included for patients’ recognition of SDM, and a 5-point scoring method was used, where “very much” was scored as 5 points, and “totally not” was scored as 1 point. Results Fifty-two patients with AF were enrolled. In terms of patients’ recognition of SDM, points of more than 4.17 out of 5 were noted, indicating recognition above the level of “very much.” The patients’ anxiety scores before SDM were 3.56 (1.2), with a decrease of 0.64 points (p < 0.001) to 2.92 (1.3) after SDM. After SDM, the number of patients who decided to take OAC increased from 76.9% to 88.5%, and the 15.4% answering “unclear” decreased to 1.9% (p = 0.006). The patients’ anxiety levels after SDM were associated with gender (p = 0.025). Conclusions The approach using SDM enhanced our understanding of the pros and cons of OAC treatment and, in patients with AF, decreased anxiety about therapeutic decisions and increased willingness to accept treatment options.

show abstract

Section: Influence Of Sdm On Patients' Decision Makingsupporting

confidence: 92%